Pharmacocinétique comparée des aminosides utilisés en dose unique journalière

Albanese, 1989, Pharmacocinétique d'un aminoside : la tobramycine, et de deux bêta-lactamines : l'azlocilline et le cefménoxime chez des patients en ventilation mécanique, Méd Mal Infect, 19, 372, 10.1016/S0399-077X(89)80251-3 Barrowcliffe, 1987, Solute permeability of the alveolar capillary barrier, Thorax, 42, 1, 10.1136/thx.42.1.1 Bauer, 1980, Amikacin pharmacokinetics in morbidly obese patients, Am J Hosp Pharm, 37, 519 Beaucaire, 1991, Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections, J Antimicrob Chemother, 27, 91, 10.1093/jac/27.suppl_C.91 Beaucaire, 1991, Arguments en faveur de l'administration des aminosides en monodose journalière chez l'homme, Lettre Infectiol, 6, 188 Beaucaire, 1993, L'amkacine en dose unique journalière chez le patient de réanimation, Méd Mal Infect, 23, 10.1016/S0399-077X(05)80987-4 Beckhouse, 1988, Altered aminoglycoside pharmacokinetics in the critically ill, Anaesth Intens Care, 16, 418, 10.1177/0310057X8801600406 BLASER J., STONE B.B., GRONER M.C., ZINNER S.H. — Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother. 487 ; 31 : 1054–60. Brody, 1984, Binding of charged ferritin to alveolar wall components and charge selectivity of macromolecular transport in permeability pulmonary edema, Circ Res, 55, 155, 10.1161/01.RES.55.2.155 Bryant, 1992, Bêta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissue, J Infect Dis, 165, 676, 10.1093/infdis/165.4.676 Chelluri, 1987, Inadequacy of standard aminoglycoside loading dose in acutely ill patients, Crit Care Med, 15, 1143, 10.1097/00003246-198712000-00015 Courcol, 1986, Pharmacokinetics of netilmicin administered once or twice-daily by subcutaneous injection, J Antimicrob Chemother, 18, 646, 10.1093/jac/18.5.646 Craig, 1988, Key pharmacokinetic parameters of antibiotic efficacy in experimental animal infections, J Drug Dev, 1, 7 Craig, 1991, Postantibiotic affect, 403 Daikos, 1990, Adaptation resistance to aminoglycoside antibiotics from first-exposure down-regulation, J Infect Dis, 162, 414, 10.1093/infdis/162.2.414 Daikos, 1991, First exposure adaptative resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use, Antimicrob Agents Chemother, 35, 117, 10.1128/AAC.35.1.117 Dasta, 1988, Variability in aminoglycoside pharmacokimetics in critically ill surgical patients, Crit Care Med, 16, 327, 10.1097/00003246-198804000-00004 De Broe, 1988, Insights into the renal handling of aminoglycosides : a guideline for prevention of nephrotoxicity, J Drug Dev, 1, 83 Delavaud, 1989, Vascularite après injection d'aminoside par voie sous-cutanée, Thèse de Médecine, 2 Della Valle, 1991, Nécroses cutanées après injections sous-cutanées d'aminosides Dorian, 1990, Etude chronopharmacocinétique de l'amikacine chez la souris, 232 Drugeon, 1993, L'amikacine administrée en dose unique journalière. Les arguments bactériologiques, Méd Mal Infect, 23, 10.1016/S0399-077X(05)80979-5 Elting, 1990, Circadian variation in serum amikacin levels, J Clin Pharmacol, 30, 798, 10.1002/j.1552-4604.1990.tb01876.x Ericsson, 1989, Prophylactic antibiotics in trauma : the hazards of underdosing, J Trauma, 29, 1356, 10.1097/00005373-198910000-00011 Evans, 1978, Use of gentamicin serum levels to individualize therapy in children, J Pediatr, 93, 133, 10.1016/S0022-3476(78)80626-X Fan, 1988, Once daily administration of netilmicin compared with twice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis, J Antimicrob Chemother, 22, 69, 10.1093/jac/22.1.69 Fantin, 1990, Factors affecting duration of in vivo postantibiotic effect for aminoglycosides against Gram-negative bacilli, J Antimicrob Chemother, 27, 829, 10.1093/jac/27.6.829 Flint, 1985, Serum level monitoring of aminoglycoside antibiotics : limitations in intensive care unit — related bacterial pneumonia, Arch Surg, 120, 99, 10.1001/archsurg.1985.01390250087014 Fuhs, 1988, Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients, Clin Pharm, 7, 207 Garraffo, 1989, Application of Bayesian estimation for prediction of an appropriate dosage regimen of amikacin, J Pharm Sci, 78, 753, 10.1002/jps.2600780911 Garraffo, 1990, Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity, Antimicrob Agents Chemother, 34, 614, 10.1128/AAC.34.4.614 Gerber, 1989, Once-daily versus thrice-daily administration of netilmicin in combination therapy of P. aeruginosa infection in a man-adaptated neutropenic animal model, Eur J Clin Microbial Infect Dis, 8, 233, 10.1007/BF01965266 Giamarellou, 1991, Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections, J Antimicrob Chemother, 27, 73, 10.1093/jac/27.suppl_C.73 Gilbert, 1991, Once-daily aminoglycoside therapy, Antimicrob Agents Chemother, 35, 399, 10.1128/AAC.35.3.399 Giuliano, 1986, In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats, J Pharmacol Exp Ther, 236, 470 Goldstein, 1991, Comparison of inoculum effects of members of the family Enterobacteriacae on cefoxitin and other cephalosporins, bêta-lactamase inhibitor combinations, and the penicillin derived components of these combinations, Antimicrob Agents Chemother, 35, 560, 10.1128/AAC.35.3.560 Haug, 1990, High dose aminoglycoside therapy in surgical ICU patients, Clin Pharmacol Ther, 47, 208 Higa, 1987, Alterations in aminoglycoside pharmacokinetics in patients with cancer, Clin Pharm, 6, 693 Holzapfel, 1991, Diffusion de l'amikacine dans les sinus chez des malades présentant une sinusite nosocomiale, 124 Hull, 1976, Gentamicin serum concentrations : pharmacokinetic predictions, Ann Intern Med, 85, 183, 10.7326/0003-4819-85-2-183 Jackson, 1988, First exposure effect of netilmicin on bacterial susceptibility as a basis for modifying the dosage regimen of aminoglycoside antibiotics, J Drug Dev, 1, 49 Jelliffe, 1991, Individualising gentamicin dosage regimens — A comparative review of selected models, data fitting methods and monitoring strategies, Clin Pharmacokinet, 21, 461, 10.2165/00003088-199121060-00006 Kahlmeter, 1980, Netilmicin : Clinical pharmacokinetics and aspects on dosage schedules. An overview, Scand J Infect Dis, 23, 74 Kaojarern, 1989, Pharmacokinetics of amikacin in hematologic malignancies, Antimicrob Agents Chemother, 33, 1406, 10.1128/AAC.33.8.1406 Kemme, 1993, Aminoglycoside dosing : a randomized prospectivestudy, Southern Med J, 86, 46, 10.1097/00007611-199301000-00011 Konrad, 1993, Studies on drug monitoring in thrice and once daily treatment with aminoglycosides, Intens Care Med, 10.1007/BF01694773 Kosirog, 1993, Aminoglycoside forecasting in neutropenic patients with cancer, Clin Pharmacokinet, 24, 79, 10.2165/00003088-199324010-00007 Korsager, 1980, Administration of gentamicin to obese patients, Int J Clin Pharmacol Ther Tox, 18, 549 Lanao, 1982, Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration, Int J Clin Pharmacol Ther Tox, 20, 271 Lanao, 1984, Influence of dose in the urinary excretion of amikacin, Int J Clin Pharmacol Ther Tox, 22, 538 Langhendries, 1993, Administration monoquotidienne de l'amikacine. Adaptation à la néonatologie pour des enfants traités avant le 3ème jour d'âge postnatal, Méd Mal Infect, 23, 10.1016/S0399-077X(05)80984-9 Lesar, 1982, Gentamicin dosage errors with four commonly used nomograms, JAMA, 248, 1190, 10.1001/jama.1982.03330100028025 Li, 1989, Prospective aduit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes, Med J Australia, 151, 224, 10.5694/j.1326-5377.1989.tb115996.x Lindsay, 1993, Optimisation of antibiotic therapy in cystic fibrosis patients, Clin Pharmacokinet, 24, 496, 10.2165/00003088-199324060-00005 Livingstone, 1988, More is better, antibiotic management after hemorrhagic shock, Ann Surg, 208, 451, 10.1097/00000658-198810000-00007 Longley, 1991, Altered aminoglycoside volume of distribution in patients with AIDS, Clin Pharm, 10, 784 Lucht, 1989, Etude chronocinétique de la nétilmicine chez l'homme, 51 Mc Allister, 1974, Gentamicin in paediatrics, Post Grad Med J, 50, 45 Maller, 1988, A study of amikacin given once versus twice daily in serious infections, J Antimicrob Chemother, 22, 75, 10.1093/jac/22.1.75 Manny, 1986, Aminoglycoside volume of distribution in hematology-oncology patients, Clin Pharm, 5, 626 Marik, 1991, The pharmacokinetics of amikacin in critically ill adult and paediatric patients : comparison of once versus twice daily dosing regimens, J Antimicrob Chemother, 27, 81, 10.1093/jac/27.suppl_C.81 Marik, 1993, Aminoglycoside volume of distribution and illnes severity in critically ill septic patients, Anaesth Intensive Care, 21, 172, 10.1177/0310057X9302100206 Mattie, 1989, Determinants of efficacy and toxicity of aminoglycosides, J Antimicrob Chemother, 24, 281, 10.1093/jac/24.3.281 Mawer, 1974, Prescribing aids for gentamicin, Br J Clin Pharmacol, 1, 45, 10.1111/j.1365-2125.1974.tb00205.x Meunier, 1981, Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients : a pilot study, J Antimicrob Chemother, 27, 129 Minuth, 1976, Inhibition of the antibacterial activity of gentamicin by urine, J Infect Dis, 133, 14, 10.1093/infdis/133.1.14 Moore, 1984, Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia, Am J Med, 77, 657, 10.1016/0002-9343(84)90358-9 Moore, 1987, Clinical response to aminoglycoside therapy : importance of the ratio of peak concentration to minimal inhibitory concentration, J Infect Dis, 155, 93, 10.1093/infdis/155.1.93 Mutz, 1993, Lung vascular permeability changes and fluid shifts in traumatized patients, 619 Nilsson, 1987, Frequencies of variants resistant to different aminoglycosides in Pseudomonas aeruginosa, J Antimicrob Chemother, 20, 255, 10.1093/jac/20.2.255 Noone, 1974, Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis, Br Med J, 1, 477, 10.1136/bmj.1.5906.477 Nordström, 1991, Single daily dose therapy with aminoglycosides, J Hosp Infect, 18, 117, 10.1016/0195-6701(91)90013-X Oparaoji, 1993, Aminoglycoside volume of distribution in postoperative patients with septic shock, Clin Pharm, 12, 131 Parker, 1993, Once-daily aminoglycoside dosing, Lancet, 341, 346, 10.1016/0140-6736(93)90143-5 Parker, 1993, Practicalities of once-daily aminoglycoside dosing, J Antimicrob Chemother, 31, 4, 10.1093/jac/31.1.4 Petitjean, 1993, Intérêt et limite de la connaissance des concentrations tissulaires d'antibiotiques, 24 Prins, 1993, Once versus thrice daily gentamicin in patients with serious infections, Lancet, 341, 335, 10.1016/0140-6736(93)90137-6 Reed, 1992, The pharmacokinetics of prophylactic antibiotics in trauma, 32, 21 Rescott, 1988, Comparison of two methods for determining in vitro post-antibiotic effects of three antibiotics on Escherichia coli, Antimicrob Agents Chemother, 32, 450, 10.1128/AAC.32.4.450 Sabath, 1970, Increasing the usefulness of antibiotics : treatment of infections caused by gram-negative bacilli, Clin Pharmacol Ther, 11, 161, 10.1002/cpt1970112161 Santre, 1992, Bronchial concentrations of amikacin delivered in a single daily dose of 15 mg/kg : eight patients Sarubbi, 1978, Amikacin serum concentrations : predictions of levels and dosage guidelines, Ann Intern Med, 89, 612, 10.7326/0003-4819-89-5-612 Sawchuk, 1977, Kinetic model for gentamicin dosing with the use of individual patients parameters, Clin Pharmacol Ther, 21, 362, 10.1002/cpt1977213362 Schwartz, 1978, Controlled investigation of the pharmacokinetics of gentamicin and tobramycine in obese subjects, J Infect Dis, 138, 499, 10.1093/infdis/138.4.499 Sheiner, 1979, Forecasting individual pharmacokinetics, Clin Pharmacol Ther, 26, 294, 10.1002/cpt1979263294 Summer, 1983, Initial aminoglycoside levels in the critically ill, Critical Care Med, 11, 948, 10.1097/00003246-198312000-00011 Ter Braak, 1990, Once-daily dosing regimen for aminoglycoside plus bêta-lactam combination therapy of serious bacterial infections : comparative trial withnetilmicin plus ceftriaxone, Am J Med, 89, 58, 10.1016/0002-9343(90)90099-Y Tran Ba Huy, 1986, Kinetics of gentamicin uptake and release in the rat — comparison of the inner ear tissues and fluids with other organs, J Clin Invest, 77, 1492, 10.1172/JCI112463 Tran Ba Huy, 1988, Aminoglycoside binding sites in the inner ears of guinea pigs, Antimicrob Agents Chemother, 32, 467, 10.1128/AAC.32.4.467 Tran Ba Huy, 1988, Aminoglycoside ototoxicity : influence of dosage regimen on drug uptake, correlation between membrane binding and clinical features, J Drug Dev, 1, 93 Traynor, 1993, The relationship of total body weight/ideal body weight ratio to aminoglycoside pharmacokinetics, Clin Pharmacol Ther, 53, 184 Triginer, 1989, Gentamicin pharmacokinetic changes related to mechanical ventilation, DICP Ann. Pharmacother, 23, 923 Triginer, 1990, Gentamicin volume of distribution in critically ill septic patients, Intens Care Med, 16, 303, 10.1007/BF01706354 Tulkens, 1991, Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin, J Antimicrob Chemother, 27, 49, 10.1093/jac/27.suppl_C.49 Van Der Auwera, 1987, Serum bactericidal activity andpostantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin, Antimicrob Agents Chemother, 31, 1061, 10.1128/AAC.31.7.1061 Van Der Auwera, 1991, Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once-daily or in three divided doses to cancer patients with urinary tract infection, Antimicrob Agents Chemother, 35, 640, 10.1128/AAC.35.4.640 Van Der Auwera, 1991, Pharmacokinetic evaluation of single daily dose amikacin, J Antimicrob Chemother, 27, 63, 10.1093/jac/27.suppl_C.63 Van Der Auwera, 1993, L'amikacine en dose uniquotidienne dans le traitement probabiliste du patient neutropénique fébrile : justification, efficacité et tolérance, Méd Mal Infect, 23, 10.1016/S0399-077X(05)80986-2 Vaudaux, 1981, Peripheral inactivation of gentamicin, J Antimicrob Chemother, 8, 17, 10.1093/jac/8.suppl_A.17 Verpooten, 1989, Once-daily dosing decreases renal accumulation of gentamicin andnetilmicin, Clin Pharmacol Ther, 45, 22, 10.1038/clpt.1989.4 Vigano, 1992, Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelo-nephritis in children, Antimicrob Agents Chemother, 36, 1499, 10.1128/AAC.36.7.1499 Viscoli, 1991, Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation, J Antimicrob Chemother, 27, 113, 10.1093/jac/27.suppl_C.113 Vogelman, 1985, Postantibiotic effects, J Antimicrob Chemother, 15, 37, 10.1093/jac/15.suppl_A.37 De Vries, 1990, Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections, Eur J Clin Microbiol Infect Dis, 9, 161, 10.1007/BF01963832 Watling, 1993, Aminoglycoside dosing considerations in intensive care unit patients, Ann Pharmacother, 27, 351, 10.1177/106002809302700319 Winters, 1971, Relation between dose and levels of gentamicin in blood, J Infect Dis, 124, S 90, 10.1093/infdis/124.Supplement_1.S90 Zaske, 1976, Increased dosage requirements of gentamicin in burn patients, J Traum, 16, 824, 10.1097/00005373-197610000-00014 Zaske, 1978, Necessity of increased doses of amikacin in burn patients, Surgery, 84, 603 Zaske, 1980, Rapid gentamicin elimination in obstretric patients, Obstet Gynecol, 56, 559 Zaske, 1980, Gentamicin dosage requirements : wide interpatients variations in 242 surgery patients with normal renal function, Surgery, 87, 164 Zaske, 1982, Gentamicin pharmacokinetics in 1640 patients : method for control of serum concentrations, Antimicrob Agents Chemother, 21, 407, 10.1128/AAC.21.3.407 Zaske, 1982, Wide interpatients variations in gentamicin dosage requirements for geriatric patients, JAMA, 248, 3112, 10.1001/jama.1982.03330230034027 Zaske, 1986, Aminoglycosides, 331 Zeitany, 1990, Increased aminoglycoside dosage requirements in hematologic malignancy, Antimicrob Agents Chemother, 34, 702, 10.1128/AAC.34.5.702 Zhanel, 1991, The postantibiotic effect : a review of in vitro and in vivo data, DICP Ann Pharmacother, 25, 153